Demand from discovery labs for so-called organ-on-a-chip based testing is growing, according to CN Bio, which has doubled capacity at the bioengineering company’s testing facility.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,